2011 to 2020 saw increase in annual prescription meds expenditures
Apr 15, 2024
Metabolic agents were the most costly category; antidiabetic agents were the mostly costly therapeutic area.
New federal rule means hospitals need written consent for pelvic, prostate exams
Apr 01, 2024
The HHS also issued a new set of guidelines clarifying a longstanding requirement that hospitals must obtain written informed consent as a condition for being reimbursed by Medicare and Medicaid.
Medicare to cover Wegovy when patients also have heart disease
Mar 22, 2024
Medicare will now cover the popular weight-loss drug Wegovy if patients using it also have heart disease, US officials announced Thursday.
Biogen is dropping controversial Alzheimer’s drug Aduhelm
Jan 31, 2024
Biogen said it will shift its focus to a newer Alzheimer’s drug, Leqembi, which it markets in a partnership with Japan-based Eisai. Leqembi received FDA approval last year.
Racial and ethnic disparities seen in use of hospice
Dec 18, 2023
Older age was associated with lower odds of short length of stay in those dually eligible for Medicare and Medicaid.
Major drug companies agree to price negotiations with US government
Oct 03, 2023
Ten drugs have been chosen for price negotiations by the Centers for Medicare & Medicaid Services.
Heart, diabetes, cancer drugs on list for Medicare price negotiations, White House says
Aug 29, 2023
Enrollees in the Medicare prescription drug program paid a total of $3.4 billion in out-of-pocket costs in 2022 for the 10 initial drugs chosen for price negotiations.
National health expenditures set to increase through 2031
Jun 16, 2023
An increase of 5.4% is projected per year, and expenditures are set to account for about 20% of GDP in 2031.
Poll: Most Americans face hassles with their insurance plans
Jun 16, 2023
Among those surveyed were those covered by Medicare and Medicaid.
2012 to 2015 saw rise in US insulin prices
Jun 16, 2023
However, the introduction of new insulin products after 2015 was followed by substantial discounting practices that lowered net prices.